Podcast: Play in new window | Download (Duration: 5:44 — 1.3MB)
Subscribe: Spotify | Email | RSS | More
Original Podcast with clickable words
https://tinyurl.com/y7npxlrd
300m additional doses of Moderna vaccine purchased by EU.
300m dáileog bhreise de vacsaín Moderna ceannaithe ag an AE.
The European Union has bought up to 300 million extra doses of the vaccine made by the pharmaceutical company Moderna, European Commission President Ursula von der Leyen said.
Tá suas le 300 milliún dáileog bhreise den vacsaín atá déanta ag an gcomhlacht cógaisíochta Moderna ceannaithe ag an Aontas Eorpach, a dúirt Uachtarán an Choimisiúin Eorpaigh Ursula von der Leyen.
These additional doses will contribute to the European Union’s aim to inoculate 70% of adults in the member states on Covid-19 by mid-September.
Cuideoidh na dáileoga breise seo le haidhm an Aontais Eorpaigh 70 faoin gcéad de dhaoine fásta sna bhallstáit a ionaclú ar covid 19 faoi lár mhí Mheán Fómhair.
Ursula von der Leyen indicated that the European Union will receive 2.6 billion doses of six different vaccines by this year.
Thug Ursula von der Leyen le fios go mbeidh 2.6 billiún dáileog de shé vacsaín éagsúla faighte ag an Aontas Eorpach faoi earr na bliana seo.
That is enough for the 450 million people living in the member states of the Union and is intended to give the surplus to neighboring countries.
Tá a dhá dhóthain sa mhéid sin don 450 milliún duine atá ina gcónaí i mballstáit an Aontais agus tá sé i gceist an farasbarr a thabhairt do thíortha comharsanachta.
Multiple doses were prescribed for fear of being needed to counteract variables on the coronaviruses.
Ordaíodh an iomad dáileog ar eagla go mbeidís de dhíth chun dul i ngleic le hathraithigh ar an gcoróinvireas.
On the contrary, however, it is reported that the European Union is still waiting for ten million vaccines from the pharmaceutical company Pfizer to be delivered in December.
Os a choinne sin, áfach, tuairiscítear go bhfuil an tAontas Eorpach fós ag fanacht le deich milliún vacsaín ón gcomhlacht cógaisíochta Pfizer a bhí le seachadadh i mí na Nollag.
Delivery of vaccines from the AstraZeneca company has also been delayed due to difficulties in manufacturing plants.
Tá moill freisin ar sheachadadh vacsaíní ón gcomhlacht AstraZeneca de bharr deacrachtaí i monarchana déantúsaíochta.